Flow cytometry and monoclonal antibody technology have led to an active field of cellular analysis, particularly in differentiation of various human leukocyte cells and tumor cells by identification of their surface antigens. For example, the immunophenotypic analysis of acute leukemia by flow cytometry has become a powerful tool for proper identification of myeloid or lymphoid lineage and has been widely used in clinical laboratories (1, 2 ) . Meanwhile, other technologies based on the specific affinity between the immobilized antibody and the associated cell surface antigens have been under development, such as the magnetic sphere immobilized with antibodies used in hematologic research and therapy (3, 4 ) . However, most of these technologies are limited in their potential for high-throughput analysis. Recently, the Luminex system, a set of polystyrene microspheres internally labeled with two spectrally distinct fluorochromes, has been developed as an array of beads in aqueous solution by use of precise ratios of these fluorochromes (5 ); this approach simultaneously detected many different organisms through modification of the beads with various antibodies. Special equipment, like that used in flow cytometry, is required for detection.
Protein microarrays that immobilize a set of proteins on the solid surface to capture their corresponding targets have potential for high-throughput analysis. The antibody microarray is one of the promising platforms for analyzing protein profiles in biological systems, based on specific interactions between antibody and antigen. Revzin et al. (6 ) developed a microfabricated cytometry platform for high-density characterization and sorting of cells. Previously, we fabricated (7 ) a multiclonal antibody microarray to capture and identify erythrocytes by use of blood group antibodies immobilized on a glass surface. After incubation, the erythrocytes in the sample could be accumulated and bound on the related spots on the microarray. As we are developing the technique for a variety of applications, we have called the method the "cell immuno-chip" method, or Cim-Chip.
In this study, we will report a similar approach for identification of leukocytes. We immobilized monoclonal antibodies to capture and detect the leukocytes by their surface antigens. CD45, the common surface antigen of leukocytes (8 ) , was used to explore the experimental conditions. Accumulation of leukocytes on the CD45 spots could be observed easily with a microscope with a digital camera. Various experimental conditions were optimized to obtain the highest leukocyte capture efficiencies, such as antibody fixing time, incubation time, and leukocyte concentration. A chip with seven antibodies for the leukocyte surface antigens was fabricated and successfully used to detect the patterns of surface antigens of leukemia M2a. This method has the potential of highthroughput detection for leukocyte surface antigens with high sensitivity and specificity.
Glass slides coated with activated agarose film were prepared (7 ). We used a PixSys5500 (Cartesian Technology Inc.) pin-based spotting robot with a SMP15 pin to deposit ϳ7.0 nL of CD45 or other antibody on the prepared slides. The printed slides were first incubated at 37°C, then stored in slide boxes at 4°C for future use. Human blood samples were kindly provided by the Hospital of Southeast University. The prepared leukocyte sample was added to the slides containing immobilized antibodies and incubated at 37°C for 120 min. The leukocytes were observed under a microscope, and the images were captured by a digital camera and analyzed by image-processing software. To increase leukocyte capture, various experimental conditions, such as the antibody fixing time, incubation time, and leukocyte concentration, were optimized. The results for the CD45 immobilization experiments showed that various experimental conditions, such as antibody fixing time, incubation time, and leukocyte concentration, affected the leukocyte capture efficiencies. We identified the following optimized conditions: 37°C, 16-h antibody fixation, 120-min incubation time, and 5.0 ϫ 10 5 leukocytes/mL, as determined by hemocytometer counting. Seven monoclonal antibodies for a set of leukocyte surface antigens (including CD13, CD15, CD33, CD34, HLA-DR, CD14, and CD45) have been immobilized on a modified slide (left side of Fig. 1 ). On the slide we spotted CD45 as the positive control spot and bovine serum albumin (BSA) as the negative control spot. CD13, CD15, CD33, CD34, and HLA-DR are positive for M2a leukemia, and CD14 is negative for M2a leukemia (9 ) . Leukocytes from 11 patients with leukemia M2a were incubated with the slides. Four spots (CD13, CD15, CD34, and CD14) are shown in the image on the right in Fig. 1 . The spots with leukocytes indicate the existence of associated cell surface antigens, and the cell counts on these spots could be used to obtain the phenotype of the leukemia. Table 1 shows the total experimental results of all 8 spots for 11 patients. The results are in agreement with the flow cytometric results.
Acute leukemia displays characteristic patterns of surface antigens (CD antigens), which facilitate their identification and proper classification and hence play an important role in instituting proper treatment plans (1 ). In current practice, the surface antigens of cells in acute leukemia are analyzed by two-, four-, or six-color flow cytometry (10 ) . However, cell immuno-chip technology can also detect cell surface antigens and might be convenient for identifying and confirming the patterns of a large number of surface antigens simultaneously and, perhaps, achieving high throughput.
